| Metric | This Period | Prior Year Period | YoY |
|---|---|---|---|
| Revenue / Net Sales | ¥150.0B | ¥145.6B | +3.0% |
| Operating Income / Operating Profit | ¥44.3B | ¥43.7B | +1.3% |
| Ordinary Income | ¥45.4B | ¥43.4B | +4.6% |
| Net Income / Net Profit | ¥31.5B | ¥30.4B | +3.4% |
| ROE | 10.3% | 9.4% | - |
For the cumulative results to Q2 of the fiscal year ending March 2026, Revenue was ¥150.0B (YoY +¥4.4B +3.0%), Operating Income was ¥44.3B (YoY +¥0.6B +1.3%), Ordinary Income was ¥45.4B (YoY +¥2.0B +4.6%), and Net Income was ¥31.5B (YoY +¥1.0B +3.4%). The company achieved higher revenue and profit, but SG&A growth (+13.1%) significantly exceeded revenue growth, causing Operating Margin to decline to 29.5% from 29.9% a year ago (-0.4pt). Gross margin improved to 49.7% from 48.4% (+1.3pt), reflecting benefits from pricing/mix and cost efficiencies, while SG&A ratio expanded to 20.2% (from 18.4% a year ago, +1.8pt), compressing operating leverage. At the ordinary income stage, a foreign exchange gain of ¥1.0B contributed to improvement, lifting Ordinary Margin to 30.3% (from 29.8% a year ago, +0.5pt).
[Revenue] Revenue was ¥150.0B (YoY +3.0%), a modest increase. As a single segment company (manufacture and sale of passenger helmets), geographic and product breakdowns are not disclosed, but steady demand through domestic and overseas sales channels underpins performance. Gross profit was ¥74.6B (Gross Margin 49.7%), up +5.8% YoY, with gross margin improving by 1.3pt from 48.4% a year ago. Improvements are presumed to stem from a combination of raw material cost control, production efficiency gains, and maintained pricing/mix. Cost of goods sold was ¥75.5B (YoY +0.4%), constrained, indicating price/mix as the main driver of gross margin expansion.
[Profitability] SG&A was ¥30.3B (YoY +13.1%), a material increase, pushing the SG&A ratio to 20.2% (up 1.8pt from 18.4%). Increases in personnel expenses, logistics, and promotion costs are assumed, raising concerns about higher fixed-cost characteristics. As a result, Operating Income was ¥44.3B (YoY +1.3%), Operating Margin 29.5% (down 0.4pt from 29.9%), with SG&A increases offsetting gross margin improvements. Non-operating income was ¥1.3B (mainly foreign exchange gains ¥1.0B, interest income ¥0.2B), and non-operating expenses were ¥0.2B (interest expense ¥0.1B, fees ¥0.1B), producing Ordinary Income of ¥45.4B (YoY +4.6%), Ordinary Margin 30.3% (up 0.5pt from 29.8%). Extraordinary items were minor, consisting only of an impairment loss on fixed assets of ¥0.2B. Pre-tax income was ¥45.2B with income taxes and others of ¥13.8B (effective tax rate 30.5%), resulting in Net Income of ¥31.5B (YoY +3.4%), Net Margin 21.0% (up 0.1pt from 20.9%). Overall, revenue and profit increased, but SG&A expansion compressed operating-stage profitability.
[Profitability] Operating Margin 29.5% (prior 29.9%), Ordinary Margin 30.3% (prior 29.8%), Net Margin 21.0% (prior 20.9%). Gross Margin 49.7% improved by 1.3pt from 48.4%, demonstrating price/mix maintenance and cost-efficiency gains, while the SG&A ratio increase to 20.2% (prior 18.4%) somewhat pressured operating-stage margins. ROE is 10.3%, explainable by Net Margin 21.0% × Total Asset Turnover 0.41x × Financial Leverage 1.21x.
[Cash Quality] DSO (Days Sales Outstanding) 76 days, DIO (Days Inventory Outstanding) 279 days, CCC (Cash Conversion Cycle) 272 days, indicating notable elongation. Inventory is ¥34.5B (YoY +24.8%), at a high level, and inventory days of 167 days (annualized) suggests stock build-up. Accounts payable ¥17.1B (YoY +72.4%) supports short-term liquidity but watch for reversal risk during inventory reduction.
[Investment Efficiency] Total Asset Turnover is 0.41x (Revenue ¥150.0B ÷ Total Assets ¥369.7B), low and indicating room to improve asset efficiency.
[Financial Soundness] Equity Ratio 82.3% (prior 85.1%), D/E ratio 0.21x, Current Ratio 476%, Quick Ratio 417%, Interest Coverage 411x (Operating Income ¥44.3B ÷ Interest Expense ¥0.1B), indicating extremely robust financials. Cash and deposits of ¥176.3B mean short-term liquidity risk is minimal.
While Operating CF, Investing CF, and Financing CF disclosures are not provided, cash trends are analyzed from balance sheet movements. Cash and deposits stand at ¥176.3B (from ¥199.4B a year ago, -¥23.1B). Major changes: operating activities generated cash via Net Income ¥31.5B, while increases in inventory (+¥6.9B) and corporate tax payable (+¥5.6B) were cash outflows; an increase in receivables (+¥1.4B) was a minor outflow. Financing activities included share buybacks (treasury stock acquisition -¥24.6B) as a major cash outflow. High inventory levels (¥34.5B, YoY +24.8%) and a small increase in receivables delay conversion of profit to cash, indicating working capital expansion. Increased payables (+¥7.2B) provided temporary cash support from higher purchases but note concentration risk on future payment timings. Overall, while profit generation supports cash creation, inventory build-up and share buybacks are primary causes of cash decline. Improving working capital management (inventory reduction and stronger collections) is key to improving free cash flow.
Of Ordinary Income ¥45.4B, non-operating income was ¥1.3B (0.9% of sales) and non-operating expenses ¥0.2B, so the bulk of Ordinary Income is operating income ¥44.3B, indicating high recurring quality. Non-operating income breakdown: foreign exchange gains ¥1.0B and interest income ¥0.2B; net foreign exchange contribution is approximately ¥0.6B (FX gains ¥1.0B - FX losses ¥0.4B), about +1.4% relative to Operating Income, limited in magnitude. Extraordinary items were only impairment loss on fixed assets ¥0.2B (0.6% of Net Income), minor. Pre-tax income ¥45.2B and taxes ¥13.8B (effective tax rate 30.5%) explain the gap between Ordinary Income and Net Income mainly by tax burden. Comprehensive income ¥38.1B vs Net Income ¥31.5B difference of ¥6.6B is mainly due to foreign currency translation adjustments ¥6.6B, reflecting FX valuation gains at overseas subsidiaries. On an accrual basis, increases in inventory (+¥6.9B) and payables (+¥7.2B) affect earnings quality, but gross margin improvement and realization of operating income suggest earnings quality is generally sound.
Full Year forecast: Revenue ¥339.5B (YoY +4.9%), Operating Income ¥83.7B (YoY -5.9%), Ordinary Income ¥83.8B (YoY -5.8%), Net Income ¥59.4B, EPS ¥116.67, Dividend ¥60. Progress through the first half: Revenue 44.2% (¥150.0B ÷ ¥339.5B), Operating Income 52.9% (¥44.3B ÷ ¥83.7B), Ordinary Income 54.2% (¥45.4B ÷ ¥83.8B), Net Income 53.0% (¥31.5B ÷ ¥59.4B). Progress rates for Operating Income, Ordinary Income, and Net Income are somewhat above the standard 50%, indicating the first half was broadly on plan. However, the full-year Operating Income plan is a YoY decline of -5.9%, implying possible significant SG&A increases or one-off charges assumed in H2. If the H1 pattern of gross margin improvement (+1.3pt) and SG&A increase (+13.1%) continues into H2, downside risk to Operating Income exists; however, if built-up inventory is sold in H2 and SG&A leverage improves with sales growth, meeting the plan remains possible.
No dividend was paid in H1, but the full-year dividend forecast is ¥60 (same as prior year assumption). With forecast EPS ¥116.67, the payout ratio is 51.4%, a mid-range level. Prior year results not disclosed, but with H1 EPS ¥60.55 (annualized), a full-year dividend of ¥60 is sustainable. Given cash and deposits ¥176.3B, equity ¥304.4B, and low leverage (D/E 0.21x), the balance sheet supports continuing dividends while covering normal investment and working capital needs. The company executed share buybacks in H1 (treasury stock -¥22.3B → -¥46.9B, approximately ¥24.6B acquired), indicating a shareholder return posture including buybacks. However, because only the dividend forecast of ¥60 is disclosed for the full year and no full-year buyback plan is provided, Total Return Ratio cannot be calculated; therefore evaluation focuses on payout ratio 51.4%. Shareholder return policy is assessed as moderate and stable.
Inventory build-up and demand digestion risk: Inventory ¥34.5B (YoY +24.8%), inventory days 167 (annualized), DIO 279 days remain elevated. While this may reflect strategic stock build for H2 sales, delayed demand digestion could lead to discounting, obsolescence, margin erosion, and additional working capital burden. Geographic or product concentration of inventory could be an added risk.
SG&A growth and pressure on operating leverage: SG&A ¥30.3B (YoY +13.1%), SG&A ratio 20.2% (up 1.8pt). Fixed-cost characteristics in personnel, logistics, and promotion are rising and materially outpacing revenue growth of +3.0%. If H2 revenue growth slows, operating margin could face further compression. The full-year Operating Income plan (-5.9% YoY) likely factors in H2 SG&A increases.
Working capital elongation pressuring cash flows: DSO 76 days, DIO 279 days, CCC 272 days show noticeable elongation. Receivables increase (+¥1.4B) and inventory build (+¥6.9B) delay cash realization of profits. Increased payables (+¥7.2B) provide short-term liquidity but may reverse during inventory reduction, leading to concentrated payment timing. Deterioration in free cash flow generation could constrain investment capacity and shareholder return flexibility.
Profitability & Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 29.5% | 8.8% (3.0%–11.0%) | +20.8pt |
| Net Margin | 21.0% | 5.4% (1.1%–8.2%) | +15.6pt |
Operating Margin 29.5% and Net Margin 21.0% both substantially exceed industry medians, reflecting high brand strength and pricing power and placing the company among the industry leaders in profitability.
Growth & Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth (YoY) | 3.0% | 11.7% (-5.4%–28.3%) | -8.7pt |
Revenue Growth 3.0% lags the industry median of 11.7%, indicating weaker growth momentum. Acceleration depends on H2 sales digestion of inventory and market expansion.
※Source: Company aggregation
Gross margin improvement vs SG&A expansion: Gross Margin 49.7% (YoY +1.3pt) evidences pricing/mix maintenance and cost-efficiency gains, with expectation for some sustainability. Conversely, SG&A Ratio 20.2% (YoY +1.8pt) expansion is pressuring Operating Margin. H2 SG&A control and revenue growth to restore operating leverage are prerequisites for achieving the full-year Operating Income plan (YoY -5.9%). The balance between sustaining gross margin improvements and managing SG&A will determine margin trajectory.
Working capital optimization opportunity: DSO 76 days, DIO 279 days, CCC 272 days show significant working capital elongation, delaying cash conversion. Inventory increase to ¥34.5B (YoY +24.8%) may be strategic for H2 sales, but the pace of demand digestion and inventory turnover improvement will be critical for next-quarter cash flow assessment. Monitor changes in procurement/payment terms and payment concentration risks for accounts payable ¥17.1B (YoY +72.4%). Optimizing working capital should materially improve free cash flow generation and expand shareholder return and investment capacity.
This report is an earnings analysis document automatically generated by AI through analysis of XBRL financial statement data. It does not constitute a recommendation to invest in any specific security. Industry benchmarks are company-compiled reference information based on public financial statements. Investment decisions are your responsibility; consult advisors as needed.